Brown William Michael 4
4 · Altimmune, Inc. · Filed Jan 4, 2019
Insider Transaction Report
Form 4
Brown William Michael
Acting Chief Financial Officer
Transactions
- Award
Stock Options (option to buy)
2019-01-02+30,000→ 30,000 totalExercise: $2.60Exp: 2024-01-02→ Common Stock, par value $0.0001 (30,000 underlying)
Footnotes (1)
- [F1]The option becomes vested and exercisable upon the filing of the Issuer's annual statement on Form 10-K with respect to the fiscal year ended December 31, 2018, generally subject to the reporting person's continued service through the vesting date.